General Hair Loss

A consensus of experts identified seven recommended interventions for AGA, including oral and topical finasteride, dutasteride, and minoxidil, while identifying 17 interventions that are not recommended.

Topical actives like Redensyl and Procapil show promising results, often in combined formulations, but clinical evidence is limited by small sample sizes and lack of standardized comparisons.

The review identifies topical melanin stimulants, antioxidants, dietary supplements, and LLLT as promising approaches for managing gray hair.

The review highlights that while FDA-approved treatments are limited, natural supplements like saw palmetto and pumpkin seed oil show promise in inhibiting 5-alpha-reductase and promoting hair density.

Micronutrients play a role in the hair follicle cycle and immune function, and deficiencies may be modifiable risk factors for alopecia, though large-scale trials are needed.

A combined rosemary and neem extract (2:1) demonstrated superior antifungal activity against dandruff-causing agents compared to ketoconazole and outperformed minoxidil in hair growth trials.

Several natural ingredients including saw palmetto, pumpkin seed oil, melatonin, caffeine, and rosemary oil showed effectiveness in treating AGA compared to baseline or minoxidil.

The review summarizes the potential of various herbal compounds, specifically highlighting rosemary oil as a promising natural alternative for managing androgenetic alopecia.

The paper outlines standard treatments for different alopecia types, noting minoxidil as first-line for androgenetic alopecia and various therapies for focal hair loss.

Chemotherapy-induced alopecia affects approximately 65% of patients; current FDA-cleared prevention is limited to scalp cooling, while regrowth options include minoxidil, PBMT, and PRP.

Medicinal plants and natural compounds show potential in promoting hair growth and preventing alopecia through anti-inflammatory, antioxidant, and metabolic improvement properties.

Traditional treatments like corticosteroids and minoxidil have limited efficacy and high recurrence rates, while new strategies like JAK inhibitors and biologics are emerging.

Hair loss is common after sleeve gastrectomy, typically occurring between months 3 and 4. Biotin supplementation shows low efficacy in reducing hair loss regardless of biotin deficiency status.

The review discusses the pathophysiology and various emerging treatments such as microneedling, LLLT, and autologous fat transfer for female pattern hair loss.

Current treatments for alopecia areata lack proven long-term effectiveness for all patients and are prone to relapse. JAK-STAT inhibitors and PRP are identified as promising future therapies.

Herbal drugs may reduce hair loss by inhibiting the 5-alpha-reductase enzyme with potentially fewer side effects than conventional pharmacological treatments.

The review concludes that while biologics can alter or slow hair aging, none can reverse the natural course of hair loss or graying.

Zinc deficiency is linked to various skin conditions, including alopecia and impaired wound healing, suggesting that adequate zinc levels are important for skin health.

The review highlights several emerging therapies, including novel excipients for oral minoxidil, dutasteride, and finasteride; topical prostaglandin modulators; low-level laser therapy; Wnt pathway activators and stem cell treatments for androgenetic alopecia; JAK inhibitors for alopecia areata; antiandrogens and pioglitazone for frontal fibrosing alopecia; and robotic-assisted follicular unit extraction for hair transplantation.